Bharat Biotech's COVID-19 vaccine "Covaxin" enters phase-3 trials

Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news